Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) — Market Cap & Net Worth
Market Cap & Net Worth: Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452)
Anhui Sunhere Pharmaceutical Excipients Co Ltd (SHE:300452) has a market capitalization of $422.68 Million (CN¥2.89 Billion) as of August 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #12981 globally and #3797 in its home market, demonstrating a 6.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anhui Sunhere Pharmaceutical Excipients Co Ltd's stock price CN¥12.32 by its total outstanding shares 234456278 (234.46 Million). See 300452 capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Anhui Sunhere Pharmaceutical Excipients Co Ltd Market Cap History: 2015 to 2026
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $647.58 Million to $422.68 Million (-0.41% CAGR).
Anhui Sunhere Pharmaceutical Excipients Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anhui Sunhere Pharmaceutical Excipients Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.49x
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap is 0.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.60x
Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap is 2.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $531.39 Million | $286.40 Million | $48.79 Million | 1.86x | 10.89x |
| 2017 | $368.39 Million | $339.36 Million | $50.34 Million | 1.09x | 7.32x |
| 2018 | $253.19 Million | $428.56 Million | $70.11 Million | 0.59x | 3.61x |
| 2019 | $286.35 Million | $464.07 Million | $84.37 Million | 0.62x | 3.39x |
| 2020 | $425.29 Million | $531.20 Million | $93.94 Million | 0.80x | 4.53x |
| 2021 | $546.42 Million | $616.71 Million | $89.25 Million | 0.89x | 6.12x |
| 2022 | $581.29 Million | $704.53 Million | $130.71 Million | 0.83x | 4.45x |
| 2023 | $479.23 Million | $839.26 Million | $161.54 Million | 0.57x | 2.97x |
| 2024 | $415.47 Million | $882.57 Million | $119.42 Million | 0.47x | 3.48x |
| 2025 | $459.05 Million | $942.80 Million | $176.55 Million | 0.49x | 2.60x |
Competitor Companies of 300452 by Market Capitalization
Companies near Anhui Sunhere Pharmaceutical Excipients Co Ltd in the global market cap rankings as of August 5, 2026.
Key companies related to Anhui Sunhere Pharmaceutical Excipients Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Anhui Sunhere Pharmaceutical Excipients Co Ltd's market cap moved from $647.58 Million to $ 422.68 Million, with a yearly change of -0.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥422.68 Million | -7.92% |
| 2025 | CN¥459.05 Million | +10.49% |
| 2024 | CN¥415.47 Million | -13.30% |
| 2023 | CN¥479.23 Million | -17.56% |
| 2022 | CN¥581.29 Million | +6.38% |
| 2021 | CN¥546.42 Million | +28.48% |
| 2020 | CN¥425.29 Million | +48.52% |
| 2019 | CN¥286.35 Million | +13.10% |
| 2018 | CN¥253.19 Million | -31.27% |
| 2017 | CN¥368.39 Million | -30.68% |
| 2016 | CN¥531.39 Million | -17.94% |
| 2015 | CN¥647.58 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Anhui Sunhere Pharmaceutical Excipients Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $422.68 Million USD |
| MoneyControl | $422.68 Million USD |
| MarketWatch | $422.68 Million USD |
| marketcap.company | $422.68 Million USD |
| Reuters | $422.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anhui Sunhere Pharmaceutical Excipients Co Ltd
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. was founded in 2001 and is based in Huainan, China.